Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 44Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 8Stomach Neoplasms 5Rectal Neoplasms 5Cholangiocarcinoma 2Stage IV Gastric Cancer With Metastasis 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Peritoneal Cancer 1Pancreatic Neoplasms 1Neutropenia 1Mesothelioma 1Liver Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Elderly Metastatic Colorectal Cancer Patients 1Colorectal Cancer Survivors 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Biliary Tract Neoplasms 1Ampullary Adenocarcinoma 1

Interventions

lenvatinib 3Surgical Procedures, Operative 3Hepatectomy 3Cholangiopancreatography, Endoscopic Retrograde 3Blood Specimen Collection 3Oxaliplatin 2Liquid Biopsy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Drug Therapy 2Base Sequence 2pembrolizumab 1gemcitabine-oxaliplatin regimen 1envafolimab 1Vascular Endothelial Growth Factor A 1Urination 1Tegafur 1Shadowing Technique, Histology 1S 1 (combination) 1Radiotherapy 1Quality of Life 1Polymerase Chain Reaction 1Photochemotherapy 1Patient Reported Outcome Measures 1Pancreaticoduodenectomy 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microbiota 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Cholangiocarcinoma × Oxaliplatin × Clear all
NCT06718257 2025-02-06

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Recruiting
300 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT05489692 2022-08-10

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

Sun Yat-sen University

Completed
43 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡